Interleukin-6 involvement in brain arteriovenous malformations

Annals of Neurology

Volumn 59, Issue 1, 2006, Pages 72-80

  Chen, Yongmei ^a,b   Pawlikowska, Ludmila ^c   Yao, Jianhua S ^a,b   Shen, Fanxia ^a,b   Zhai, Wenwu ^d   Achrol, Achal S ^a,b   Lawton, Michael T ^a,e   Kwok, Pui Yan ^c   Yang, Guo Yuan ^a,b,e   Young, William L ^a,b,e,f  

^a Center for Cerebrovascular Research   (United States)

^b Department of Anesthesia and Perioperative Care ^*  (United States)

^c Cardiovascular Research Institute   (United States)

^d Department of Pharmacology and Toxicology and Mass Spectrometry Core Facility

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE ELASTASE; MESSENGER RNA; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANGIOGENESIS; ARTICLE; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; DNA POLYMORPHISM; ENDOTHELIUM CELL; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ADULT; AGED; ANIMALS; BRAIN; CELLS, CULTURED; ENDOTHELIAL CELLS; GENOTYPE; HUMANS; INTERLEUKIN-6; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; MATRIX METALLOPROTEINASES; MICE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; STATISTICS;

EID: 29944437617     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20697     Document Type: Article

References (33)

1. Fleetwood IG, Steinberg GK. Arteriovenous malformations. Lancet 2002;359:863-873.
2. Fee D, Grzybicki D, Dobbs M, et al. Interleukin 6 promotes vasculogenesis of murine brain microvessel endothelial cells. Cytokine 2000;12:655-665.
3. Hernandez-Rodriguez J, Segarra M, Vilardell C, et al. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism. Circulation 2003;107:2428-2434.
4. Banerjee K, Biswas PS, Kim B, et al. CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. J Immunol 2004;172:1237-1245.
5. Huang SP, Wu MS, Shun CT, et al. Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma. J Biomed Sci 2004;11:517-527.
6. Aoki Y, Jaffe ES, Chang Y, et al. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 1999;93:4034-4043.
7. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992;258:1798-1801.
8. Salcedo R, Resau JH, Halverson D, et al. Differential expression and responsiveness of chemokine receptors (CXCR 1-3) by human microvascular endothelial cells and umbilical vein endothelial cells. FASEB J 2000;14:2055-2064.
9. Li A, Dubey S, Varney ML, et al. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 2003;170:3369-3376.
10. Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia 2002;39:279-291.
11. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003;92:827-839.
12. Pawlikowska L, Tran MN, Achrol AS, et al. Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations. Stroke 2004;35:2294-2300.
13. Halim AX, Singh V, Johnston SC, et al. Characteristics of brain arteriovenous malformations with coexisting aneurysms: a comparison of two referral centers. Stroke 2002;33:675-679.
14. Hashimoto G, Inoki I, Fujii Y, et al. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem 2002;277:36288-36295.
15. Yao JS, Chen Y, Zhai W, et al. Minocycline exerts multiple inhibitory effects on vascular endothelial growth factor-induced smooth muscle cell migration: the role of ERK1/2, PI3K, and matrix metalloproteinases. Circ Res 2004;95:364-371.
16. Chen Y, Xu B, Arderiu G, et al. Retroviral delivery of homeobox d3 gene induces cerebral angiogenesis in mice. J Cereb Blood Flow Metab 2004;24:1280-1287.
17. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-1376.
18. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000;275:18138-18144.
19. Rundek T, Elkind MS, Pittman J, et al. Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study. Stroke 2002;33:1420-1423.
20. Jones KG, Brull DJ, Brown LC, et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 2001;103:2260-2265.
21. Brull DJ, Leeson CP, Montgomery HE, et al. The effect of the interleukin-6-174G > C promoter gene polymorphism on endothelial function in healthy volunteers. Eur J Clin Invest 2002;32:153-157.
22. Acalovschi D, Wiest T, Hartmann M, et al. Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 2003;34:1864-1869.
23. Power C, Henry S, Del Bigio MR, et al. Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann Neurol 2003;53:731-742.
24. Belayev L, Saul I, Curbelo K, et al. Experimental intracerebral hemorrhage in the mouse: histological, behavioral, and hemodynamic characterization of a double-injection model. Stroke 2003;34:2221-2227.
25. Gaudino M, Andreotti F, Zamparelli R, et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation 2003;108(suppl 1):II195-II199.
26. Pola R, Flex A, Gaetani E, et al. Synergistic effect of -174 G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke. Stroke 2003;34:881-885.
27. Flex A, Gaetani E, Pola R, et al. The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease. Eur J Vasc Endovasc Surg 2002;24:264-268.
28. Ferroni P, Basili S, Martini F, et al. Serum metalloproteinase 9 levels in patients with coronary arten' disease: a novel marker of inflammation. J Investig Med 2003;51:295-300.
29. Dasu MR, Barrow RE, Spies M, Herndon DN. Matrix metalloproteinase expression in cytokine stimulated human dermal fibroblasts. Burns 2003;29:527-531.
30. Chen Y, Fan Y-F, Zhu Y, et al. Matrix metalloproteinase-9 is associated with myeloperoxidase expression in BAVM. J Neurosurg Anesthesiol 2005;11:221.
31. Voronov E, Shouval DS, Krelin Y, et al. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci U S A 2003;100:2645-2650.
32. Meager A. Cytokine regulation of cellular adhesion molecule expression in inflammation. Cytokine Growth Factor Rev 1999;10:27-39.
33. Halim AX, Johnston SC, Singh V, et al. Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke 2004;35:1697-1702.